Summary
Thermo Fisher Scientific Inc. (TMO) announced on August 2, 2016, through its wholly-owned finance subsidiary, Thermo Fisher Scientific (Finance I) B.V., the issuance and sale of €600 million in Floating Rate Senior Notes due 2018. The notes are fully and unconditionally guaranteed by the parent company, Thermo Fisher Scientific Inc. The primary use of the net proceeds, expected to be approximately €597.4 million after expenses, is to repay outstanding indebtedness incurred to finance the recent acquisition of Affymetrix, Inc. Any remaining funds will be allocated for general corporate purposes, which could include debt repayment, capital expenditures, future acquisitions, working capital, or share repurchases. This offering represents a strategic move to refinance acquisition-related debt and maintain financial flexibility.
Key Highlights
- 1Thermo Fisher Scientific Inc. (TMO) is issuing €600 million in Floating Rate Senior Notes due 2018.
- 2The notes are being issued by a wholly-owned finance subsidiary, Thermo Fisher Scientific (Finance I) B.V.
- 3The parent company, Thermo Fisher Scientific Inc., is providing a full and unconditional guarantee for the notes.
- 4The offering is expected to generate net proceeds of approximately €597.4 million.
- 5A significant portion of the proceeds will be used to repay the term loan facility used to fund the Affymetrix, Inc. acquisition.
- 6Remaining proceeds will be used for general corporate purposes, including potential debt refinancing, capital expenditures, acquisitions, and share repurchases.